Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 30 peer-reviewed journal articles Updated
Pain Management

Are Opioids Effective for CRPS Nerve Pain?

At a Glance

Opioids are generally not effective for treating CRPS nerve pain and can actually make your pain worse by increasing nervous system sensitivity (opioid-induced hyperalgesia). Meaningful relief comes from nerve-targeting medications like gabapentin, ketamine, and rehabilitative therapies.

In this answer

2 sections

01

The Backfire Effect: Opioid-Induced Hyperalgesia

02

Targeting the Root of CRPS Nerve Pain

When you are living with the excruciating pain of Complex Regional Pain Syndrome (CRPS), it is natural to expect that strong painkillers like opioids will provide relief. However, opioids are generally not effective for treating CRPS nerve pain and, in many cases, can actually make your pain worse. Current clinical guidelines do not recommend relying on long-term opioid medications for CRPS [1][2][3]. Instead, successful management requires targeting the specific nerve pathways and inflammatory responses that are actively driving the disease [4][5].

Safety Warning: Do not stop taking opioid medications suddenly. If you are currently taking opioids, stopping abruptly can cause severe withdrawal symptoms and massive pain flares. Always work with your doctor on a safe, gradual tapering plan.

The Backfire Effect: Opioid-Induced Hyperalgesia

To understand why opioids frequently fail or complicate CRPS, it helps to understand a paradoxical effect known as opioid-induced hyperalgesia (OIH), a condition where taking opioid medications actually increases your central nervous system’s sensitivity to pain [6][7][8]. In OIH, opioids trigger complex changes in the spinal cord and brain that amplify pain signals rather than block them [9][10][11].

Furthermore, opioids can worsen the underlying inflammation associated with CRPS. Opioid medications can activate immune cells in the nervous system called glial cells (specifically microglia), triggering them to release pro-inflammatory chemicals [12][13][14]. Because CRPS is already characterized by severe neuroinflammation [3][15][16], introducing opioids can essentially throw fuel on the fire, worsening nerve sensitization and promoting chronic pain.

Targeting the Root of CRPS Nerve Pain

Because CRPS involves a pathologically sensitized nervous system, treatment must calm these hyperactive nerves directly [4][5][2]. First-line medications for CRPS are fundamentally different from opioids because they target specific structural mechanisms in your nerves. Be aware that unlike fast-acting painkillers, these nerve medications often take weeks to build up in your system and show full benefit.

  • Gabapentinoids: Medications like gabapentin and pregabalin are commonly used to manage CRPS [17][18][19]. They work by binding to specific calcium channels on your nerve cells [20][21][22]. By doing so, they limit the influx of calcium, which directly reduces the amount of pain-signaling neurotransmitters your nerves release [20][21]. This physically calms the overactive nerve signaling. Note: These medications often need to be gradually increased over time and can cause side effects like dizziness and sedation.
  • NMDA Receptor Antagonists: Medications like ketamine are sometimes used to target receptors in the brain and spinal cord that are responsible for central sensitization [23][24][25]. Ketamine can help “reset” the sensitized pain pathways and has even been used to manage opioid-induced hyperalgesia [26][27][28]. Note: Ketamine treatments require careful clinical monitoring due to potential dissociative and cardiovascular side effects.
  • Multimodal Care: Effective CRPS treatment is highly personalized and typically combines medications that quiet nerve pain with physical therapy, interventional procedures (like sympathetic nerve blocks or spinal cord stimulators), and other rehabilitative approaches [23][29][30]. This may include mirror therapy, an established technique that uses visual feedback from a mirror to help “retrain” the brain’s pain pathways.

Understanding that opioids can be counterproductive to managing central nervous system sensitization is a critical step in building an effective treatment plan. Focusing on therapies that calm nerve activity and reduce neuroinflammation offers a much better path to meaningful pain management.

Common questions in this guide

Do opioids help with CRPS nerve pain?
Opioids are generally not effective for Complex Regional Pain Syndrome and are not recommended for long-term use. In many cases, they can actually worsen your nerve pain by increasing your nervous system's sensitivity to pain signals.
What is opioid-induced hyperalgesia?
Opioid-induced hyperalgesia is a paradoxical condition where taking opioid medications increases your central nervous system's sensitivity to pain. Instead of blocking pain signals, the drugs trigger changes that amplify your pain and worsen neuroinflammation.
Is it safe to stop taking my opioid medication right away?
Never stop taking opioid medications suddenly, as abrupt withdrawal can cause severe physical symptoms and massive pain flares. You must work closely with your healthcare provider to create a safe, gradual tapering schedule.
What are the best medications for CRPS pain?
First-line treatments typically include nerve-targeting medications like gabapentin or pregabalin, which physically calm overactive nerve signaling. Doctors may also use NMDA receptor antagonists, like ketamine, to help reset sensitized pain pathways.
What non-medication treatments work for CRPS?
Effective CRPS management usually requires a multimodal approach. This includes physical therapy, mirror therapy to help retrain the brain's pain pathways, and interventional procedures like sympathetic nerve blocks or spinal cord stimulation.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Since opioids are generally not recommended for CRPS, what is our timeline and plan for safely tapering my current pain medication?
  2. 2.Am I a candidate for nerve-targeting medications like gabapentin or pregabalin, and what side effects should I watch for as we adjust the dose?
  3. 3.Would NMDA receptor antagonists, like a ketamine infusion, be an appropriate option to help 'reset' my pain pathways?
  4. 4.How can we incorporate interventional pain procedures, such as nerve blocks or spinal cord stimulation, into my treatment plan?
  5. 5.Are there specialized rehabilitative techniques, like mirror therapy, that I should be starting now?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

Can CRPS Go Into Full Remission? Prognosis ExplainedDoes Complex Regional Pain Syndrome (CRPS) Spread?Can Vitamin C Prevent CRPS After Surgery or Fracture?How Does IV Ketamine Infusion Therapy Treat CRPS?How Does Mirror Therapy Work for CRPS?How Does Weather and Temperature Affect CRPS Pain?Is CRPS Type 2 More Severe Than Type 1? | Inciteful MedExercising with CRPS: Should You Push Through Pain?How to Tell if a CRPS Sympathetic Nerve Block WorkedWhat Causes CRPS After a Fracture or Surgery?What Conditions Are Commonly Mistaken for CRPS?SCS vs DRG Stimulation for CRPS: What's the Difference?Why Are Bisphosphonates Used for CRPS?Why Does a CRPS Limb Turn Cold?

References

References (30)
  1. 1

    The complex regional pain syndrome: Diagnosis and management strategies.

    Alshehri FS

    Neurosciences (Riyadh, Saudi Arabia) 2023; (28(4)):211-219 doi:10.17712/nsj.2023.4.20230034.

    PMID: 37844940
  2. 2

    Algorithm for multimodal medication therapy in patients with complex regional pain syndrome.

    Chang MC, Park D

    Journal of Yeungnam medical science 2023; (40(Suppl)):S125-S128 doi:10.12701/jyms.2023.00360.

    PMID: 37434359
  3. 3

    Complex regional pain syndrome-up-to-date.

    Birklein F, Dimova V

    Pain reports 2017; (2(6)):e624 doi:10.1097/PR9.0000000000000624.

    PMID: 29392238
  4. 4

    Complex Regional Pain Syndrome.

    Neumeister MW, Romanelli MR

    Clinics in plastic surgery 2020; (47(2)):305-310 doi:10.1016/j.cps.2019.12.009.

    PMID: 32115056
  5. 5

    Different Types of Pain in Complex Regional Pain Syndrome Require a Personalized Treatment Strategy.

    Mangnus TJP, Dirckx M, Huygen FJPM

    Journal of pain research 2023; (16()):4379-4391 doi:10.2147/JPR.S432209.

    PMID: 38162406
  6. 6

    Attitudes Towards and Management of Opioid-induced Hyperalgesia: A Survey of Chronic Pain Practitioners.

    Kum E, Buckley N, de Leon-Casasola O, et al.

    The Clinical journal of pain 2020; (36(5)):359-364 doi:10.1097/AJP.0000000000000814.

    PMID: 32028382
  7. 7

    Knowing the Enemy Is Halfway towards Victory: A Scoping Review on Opioid-Induced Hyperalgesia.

    Sampaio-Cunha TJ, Martins I

    Journal of clinical medicine 2022; (11(20)) doi:10.3390/jcm11206161.

    PMID: 36294488
  8. 8

    Evolution of Analgesic Tolerance and Opioid-Induced Hyperalgesia Over 6 Months: Double-Blind Randomized Trial Incorporating Experimental Pain Models.

    Rowbotham MC, Wallace M

    The journal of pain 2020; (21(9-10)):1031-1046 doi:10.1016/j.jpain.2020.01.005.

    PMID: 32006699
  9. 9

    A neural circuit from paratenial thalamic nucleus to anterior cingulate cortex for the regulation of opioid-induced hyperalgesia in male rats.

    Zhu PF, Wang X, Nie B, et al.

    Neurobiology of disease 2024; (203()):106745 doi:10.1016/j.nbd.2024.106745.

    PMID: 39603279
  10. 10

    PAG neuronal NMDARs activation mediated morphine-induced hyperalgesia by HMGB1-TLR4 dependent microglial inflammation.

    Mo J, Lu Z, Peng J, et al.

    Journal of psychiatric research 2023; (164()):150-161 doi:10.1016/j.jpsychires.2023.05.082.

    PMID: 37352811
  11. 11

    Differential Spinal and Supraspinal Activation of Glia in a Rat Model of Morphine Tolerance.

    Jokinen V, Sidorova Y, Viisanen H, et al.

    Neuroscience 2018; (375()):10-24 doi:10.1016/j.neuroscience.2018.01.048.

    PMID: 29421434
  12. 12

    The therapeutic potential of phytochemicals in morphine tolerance: targeting microglia-mediated neuroinflammation.

    Shi R, Jin T, Xu W, Liang Y

    Frontiers in pharmacology 2025; (16()):1669257 doi:10.3389/fphar.2025.1669257.

    PMID: 41282620
  13. 13

    Toll-Like Receptor 4 (TLR4)/Opioid Receptor Pathway Crosstalk and Impact on Opioid Analgesia, Immune Function, and Gastrointestinal Motility.

    Zhang P, Yang M, Chen C, et al.

    Frontiers in immunology 2020; (11()):1455 doi:10.3389/fimmu.2020.01455.

    PMID: 32733481
  14. 14

    Emodin relieves morphine-stimulated BV2 microglial activation and inflammation through the TLR4/NF-κB/NLRP3 pathway.

    Li S, Tang S, Dai L, et al.

    Neuroreport 2024; (35(8)):518-528 doi:10.1097/WNR.0000000000002034.

    PMID: 38597275
  15. 15

    Spatial imaging analysis of cutaneous nerve-myeloid cell interactions in chronic complex regional pain syndrome.

    Karrasch JF, O'Neil TR, Baharlou H, et al.

    Pain 2026; (167(4)):893-914 doi:10.1097/j.pain.0000000000003845.

    PMID: 41325586
  16. 16

    Is the brain of complex regional pain syndrome patients truly different?

    van Velzen GA, Rombouts SA, van Buchem MA, et al.

    European journal of pain (London, England) 2016; (20(10)):1622-1633 doi:10.1002/ejp.882.

    PMID: 27161331
  17. 17

    Recovery from acute pediatric complex regional pain syndrome type I after ankle sprain by early pharmacological and physical therapies in primary care: a case report.

    Takahashi Y, Tominaga T, Okawa K, Tanaka K

    Journal of pain research 2018; (11()):2859-2866 doi:10.2147/JPR.S164708.

    PMID: 30519087
  18. 18

    Use of anticonvulsants and antidepressants for treatment of complex regional pain syndrome: a literature review.

    Javed S, Abdi S

    Pain management 2021; (11(2)):189-199 doi:10.2217/pmt-2020-0060.

    PMID: 33183126
  19. 19

    A randomized controlled trial of amitriptyline versus gabapentin for complex regional pain syndrome type I and neuropathic pain in children.

    Brown S, Johnston B, Amaria K, et al.

    Scandinavian journal of pain 2016; (13()):156-163 doi:10.1016/j.sjpain.2016.05.039.

    PMID: 28850523
  20. 20

    Mirogabalin and emerging therapies for diabetic neuropathy.

    Javed S, Alam U, Malik RA

    Journal of pain research 2018; (11()):1559-1566 doi:10.2147/JPR.S145999.

    PMID: 30174455
  21. 21

    Outside-in regulation of the readily releasable pool of synaptic vesicles by α2δ-1.

    Martínez San Segundo P, Terni B, Burgueño J, et al.

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2020; (34(1)):1362-1377 doi:10.1096/fj.201901551R.

    PMID: 31914622
  22. 22

    Mechanisms of the gabapentinoids and α 2 δ-1 calcium channel subunit in neuropathic pain.

    Patel R, Dickenson AH

    Pharmacology research & perspectives 2016; (4(2)):e00205 doi:10.1002/prp2.205.

    PMID: 27069626
  23. 23

    The Analgesic Efficacy of Therapies Used for Complex Regional Pain Syndrome: A Systematic Review.

    Shekarsarai C, McQuibban NA, Gullick N

    Cureus 2025; (17(9)):e91697 doi:10.7759/cureus.91697.

    PMID: 40917914
  24. 24

    Ketamine for Complex Regional Pain Syndrome: A Narrative Review Highlighting Dosing Practices and Treatment Response.

    Lii TR, Singh V

    Anesthesiology clinics 2023; (41(2)):357-369 doi:10.1016/j.anclin.2023.03.005.

    PMID: 37245947
  25. 25

    Anesthetic Management of a Complex Regional Pain Syndrome (CRPS) Patient With Ketamine.

    Mundluru T, Saraghi M

    Anesthesia progress 2020; (67(4)):219-225 doi:10.2344/anpr-67-02-07.

    PMID: 33393601
  26. 26

    Innovative Management of Opioid-Induced Hyperalgesia Using Lidocaine Infusion: A Case Report.

    Bautista A, Ferguson R, Elmati PR, Bautista A

    Cureus 2024; (16(8)):e66376 doi:10.7759/cureus.66376.

    PMID: 39246939
  27. 27

    Memantine treatment improves opioid-induced hyperalgesia symptoms: randomize clinical trial.

    Anjomshoaa A, Zolghadriha A, Haj-Seyed-Taghia NS, et al.

    Scientific reports 2025; (15(1)):43890 doi:10.1038/s41598-025-23068-x.

    PMID: 41398329
  28. 28

    The Enigma of Low-Dose Ketamine for Treatment of Opioid-Induced Hyperalgesia in the Setting of Psychosocial Suffering and Cancer-Associated Pain.

    Willeford A, Atayee RS, Winters KD, Mesarwi P

    Journal of pain & palliative care pharmacotherapy 2018; (32(4)):248-255 doi:10.1080/15360288.2019.1615028.

    PMID: 31125279
  29. 29

    Effect and mechanisms of exercise for complex regional pain syndrome.

    Li TS, Wang R, Su X, Wang XQ

    Frontiers in molecular neuroscience 2023; (16()):1167166 doi:10.3389/fnmol.2023.1167166.

    PMID: 37206984
  30. 30

    Graded motor imagery modifies movement pain, cortical excitability and sensorimotor function in complex regional pain syndrome.

    Strauss S, Barby S, Härtner J, et al.

    Brain communications 2021; (3(4)):fcab216 doi:10.1093/braincomms/fcab216.

    PMID: 34661105

This page explains the medical mechanisms behind CRPS pain for educational purposes only. Never stop taking opioid medications abruptly; always consult your doctor to discuss a safe tapering plan and appropriate nerve-targeting treatments.

Get notified when new evidence is published on Complex regional pain syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.